Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 26, 2015 5:42 PM ET

Biotechnology

Company Overview of Moderna Therapeutics, Inc.

Company Overview

Moderna Therapeutics, Inc. develops messenger RNA therapeutics. The company provides in vivo drug modality that produces human proteins or antibodies inside patient cells. It also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. The company focuses on disease areas, such as inherited genetic disorders, hemophilic and blood factors, and oncology. Moderna Therapeutics, Inc. has strategic option agreements with AstraZeneca and Alexion Pharmaceuticals, Inc.; and strategic collaborations with Karolinska Institutet, Institut Pasteur, and Karolinska University Hospital. The company was incorporated in 2009 and is based...

200 Tech Square

Cambridge, MA 02139

United States

Founded in 2009

Phone:

617-714-6500

Fax:

617-583-1998

Key Executives for Moderna Therapeutics, Inc.

Founding Chief Executive Officer, President and Director
Age: 41
Co-Founder, Chairman and Member of Technology Advisory Board
Age: 51
Chief Financial Officer
President of Research and Development
Age: 60
Senior Vice President of Technology Strategy
Age: 55
Compensation as of Fiscal Year 2014.

Moderna Therapeutics, Inc. Key Developments

Moderna Therapeutics, Inc. Names Tal Zaks as Chief Medical Officer, Effective March 16, 2015

Moderna Therapeutics, Inc. announced that Tal Zaks, M.D., Ph.D., will join Moderna's executive leadership team as chief medical officer, effective March 16. Prior to joining Moderna, Dr. Zaks was senior vice president and head of Global Oncology at Sanofi.

Moderna Therapeutics Enters into Research Collaboration with Institut Pasteur

Moderna Therapeutics has entered into a long-term strategic research collaboration with Institut Pasteur. The contract has been signed to discover and develop drugs and vaccines using its mRNA Therapeutics platform. It will be managed by its venture company, Valera, which is focused on the advancement of vaccines and therapeutics for the prevention and treatment of viral, bacterial and parasitic infectious diseases. Under the deal, Valera will sponsor programmes of preclinical and clinical research at the Institut Pasteur, aimed at discovering and developing new approaches to combat known and emerging viral and bacterial diseases.

Moderna Therapeutics, Inc. Presents at Leerink's Global Healthcare Conference, Feb-11-2015 01:50 PM

Moderna Therapeutics, Inc. Presents at Leerink's Global Healthcare Conference, Feb-11-2015 01:50 PM. Venue: Waldorf Astoria New York, New York, New York, United States. Speakers: Lorence H. Kim, Chief Financial Officer, Stephane Bancel, CEO.

Similar Private Companies By Industry

Company Name Region
TrackFive Diagnostics, Inc. United States
Neurogen Corporation United States
Meso Scale Technologies, LLC United States
Vascular Strategies LLC United States
QIAGEN Gaithersburg, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 19, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Moderna Therapeutics, Inc., please visit www.modernatx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.